Veterinary medicine not approved for treating COVID19: MCAZ

3 weeks ago
215 Views

The Medicines Control Authority of Zimbabwe has warned on use of ivermectin injection for the prevention or treatment of covid19.

In a statement, Medicines Control Authority of Zimbabwe Acting Director General Mr. Richard Rukwata said in view of the growing number of inquiries ad reports received concerning use of veterinary ivermectin injection for the prevention or treatment of covid19, the Medicines Control Authority of Zimbabwe (MCAZ) is strongly advising members of the public, veterinary medicines general dealers and healthcare practitioners against use of veterinary formulations of ivermectin injection in humans for the prevention or treatment of covid19, or any other health condition.

“Veterinary ivermectin is a product approved for the treatment and control of parasites in animals only” added Rukwata.

According to the 81st Joint FAO/WHO Expert Committee on Food Additives (JECFA) meeting, 2015 report vermectin is a macrocyclic lactone that is a member of the avermectin series and is widely used as a broad-spectrum antiparasitic endectocide against nematode and arthropod parasites in food-producing animals.

Rukwata asserted that veterinary ivermectin is not indicated nor is it approved by MCAZ for use in humans. Furthermore, Section 88 of the Medicines and Allied Substances Control (General) Regulations 1991, SI 150 of 1991 prohibits the use of any veterinary medicine for the treatment of humans.

“Any researchers interested in exploring novel therapeutics for covid19 can only do so under clinical trial settings, or in any other manner after prior authorisation by MCAZ. Unapproved uses of medicines can lead to negative health problems, worsening of your condition or death” read the statement.

The Authority therefore recommends that patients and healthcare providers use standard treatment guidelines and protocols approved by Ministry of Health and Child Care as guided by the World Health Organisation.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *